NCT07068399Recruiting
Use of Shock Wave Therapy for Neo-Vascularisation in Non-critical Coronary Artery Disease: Validation by Quantitative Cardiac MRI Perfusion
Source: ClinicalTrials.gov · Last updated 16 Jul 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This is a randomised controlled trial aimed to demonstrate the effect of cardiac extracorporeal shock wave therapy (CSWT) on the angiogenesis effect of myocardium by determining myocardial perfusion and left ventricular function in patients with coronary artery disease (CAD) when measured by cardiac MRI before and after the treatment.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- First submitted
- 7 Jul 2025
- Start date
- 1 Sept 2020
- Primary completion date
- 1 Jan 2026
- Lead sponsor
- The University of Hong Kong
- Diseases
- Coronary artery disease
- NCT number
- NCT07068399
What you commit to
- Study type: Interventional
- Planned participants: 100
- From 1 Sept 2020 to the primary completion date, 1 Jan 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Recent myocardial infarction within 6 months.
Lab values
- Contraindication to contrast enhanced stress Cardiac Magnetic Resonance (eg. Estimated GFR \<30ml/min/1.73m2, severe allergy to gadolinium based contrast agent, contraindication to adenosine)
Age
- Age \< 18 years,
Other
- Pregnancy or lactation.
- Life expectancy \<24 months
- Haemodynamically unstable
- Participation in other clinical trial within 6 months of enrollment.
- Unable to consent to or perform components of the study.
Who the study is looking for
- Patients with symptoms of coronary artery disease
- Patients without obstructive coronary artery disease
- with LVEF not \< 40%.
Age in the registry: 18 years to 80 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| HKU Li Ka Shing Faculty of Medicine Coordinator of this site? Confirm its status | Hong Kong | Hong Kong SAR China | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.